Investment Business Weekly
Welcome to VerticalNews!
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Par Pharmaceutical Companies, Inc.
Par Pharmaceutical Announces the Resignation of Its Chief Financial Officer
June 20th, 2010
Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced the resignation of Lawrence A. Kenyon, executive vice president and chief financial officer, effective June 30, 2010, to pursue other opportunities. Michael A. Tropiano, Par's Treasurer, will replace Mr. Kenyon.
Mr. Tropiano, 52, joined Par in August 2005 as Vice President and Treasurer. During his tenure, Mr. Tropiano has led several initiatives including building a Financial, Planning and Analysis team, developing the Company's three-year strategic plan, as well the early redemption of the Company's convertible debentures. Prior to joining Par, Mr. Tropiano served as Vice President and Corporate Treasurer of...
Click here for more articles from Par Pharmaceutical Companies, Inc.
Source: Investment Business Weekly (2010-06-20)